PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27129261-2	2016	We show by using lipidomics that thrombin-activated human platelets generate a new type of eicosanoid that both stimulates and primes human neutrophil integrin (Mac-1) expression, in response to formylmethionylleucylphenylalanine.	N-Formylmethionine Leucyl-Phenylalanine	195-229	integrin subunit alpha M	Homo sapiens	161-166	
28554732-8	2017	We demonstrated in vitro that atorvastatin 10 muM reduced formyl-methionyl-leucyl phenylalanine-induced upregulation of CD11b expression and changes in calcium flux, reflecting an ability to decrease neutrophil activation.	N-Formylmethionine Leucyl-Phenylalanine	58-95	integrin subunit alpha M	Homo sapiens	120-125	
26432981-4	2015	In this study, our data showed that osthol potently inhibited the production of superoxide anion (O2( -)) and reactive oxidants derived therefrom as well as expression of CD11b in N-formylmethionylleucylphenylalanine (FMLP)-activated human neutrophils.	N-Formylmethionine Leucyl-Phenylalanine	180-216	integrin subunit alpha M	Homo sapiens	171-176	
24239856-8	2014	NPS also increased N-formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated CD11b integrin levels in eosinophils from subjects with high IgE.	N-Formylmethionine Leucyl-Phenylalanine	60-64	integrin subunit alpha M	Homo sapiens	77-82	
17386075-4	2007	In order to test this hypothesis, we explored the responsiveness of in vivo transmigrated as well as peripheral monocytes, in terms of CD11b expression and H(2)O(2) production towards the bacterial-related peptide formylmethionylleucylphenylalanine (fMLP) by the use of a skin chamber technique.	N-Formylmethionine Leucyl-Phenylalanine	214-248	integrin subunit alpha M	Homo sapiens	135-140	
15294914-12	2004	Subcellular fractionation studies in polymorphonuclear leukocytes (PMN) revealed similar patterns of redistribution of BAP31 and CD11b/CD18 from fractions enriched in secondary granules to the plasma membrane following stimulation with formylmethionylleucylphenylalanine (fMLP).	N-Formylmethionine Leucyl-Phenylalanine	236-270	integrin subunit alpha M	Homo sapiens	129-134	
10925557-9	2000	After BMT, fluorescent cytometric analysis of polymorphonuclear leukocytes showed normalized cellular granularity and a normal increase in CD11b expression on N-formylmethionyl-leucyl-phenylalanine stimulation.	N-Formylmethionine Leucyl-Phenylalanine	159-197	integrin subunit alpha M	Homo sapiens	139-144	
7531948-5	1995	Butanol and PTX also significantly reduced the upregulation of CD11b/CD18 by f-methionyl-leucyl-phenylalanine (fMLP) and platelet-activating factor (PAF) but not by phorbol myristate acetate (PMA).	N-Formylmethionine Leucyl-Phenylalanine	111-115	integrin subunit alpha M	Homo sapiens	63-68	
8393328-3	1993	Using monoclonal antibodies and flow cytometry, we investigated the effect of adenosine on the increase in plasma membrane expression of Mac-1 which occurs following stimulation of neutrophils with the chemotactic peptide N-formylmethionylleucylphenylalanine (FMLP).	N-Formylmethionine Leucyl-Phenylalanine	222-258	integrin subunit alpha M	Homo sapiens	137-142	
16600024-6	2006	F-met-leu-phe increased CD11b, CD35 and CD18 and decreased CD62L expression in all groups, with a greater CD35 increase in severe asthma.	N-Formylmethionine Leucyl-Phenylalanine	0-13	integrin subunit alpha M	Homo sapiens	24-29	
8869422-5	1996	Neutrophil adhesion molecule expression and the expression of CD11b in response to stimulation with formylmethionyl-leucyl-phenylalanine and lipopolysaccharide were determined before and after 24 h of lipid-containing parenteral nutrition.	N-Formylmethionine Leucyl-Phenylalanine	100-136	integrin subunit alpha M	Homo sapiens	62-67	
8869422-9	1996	Neutrophil response to stimulation with formylmethionyl-leucyl-phenylalanine and lipopolysaccharide as determined by CD11b expression was unaffected by parenteral nutrition.	N-Formylmethionine Leucyl-Phenylalanine	40-76	integrin subunit alpha M	Homo sapiens	117-122	
7560242-6	1995	Compared to CS-GCW, TS-GCW before therapy increased the expression of the beta 2 integrin CD11b and the chemotactic receptor for the oligopeptide N-formyl methionyl leucyl phenylalanine (FMLP-R) while it reduced the expression of L-selectin.	N-Formylmethionine Leucyl-Phenylalanine	146-185	integrin subunit alpha M	Homo sapiens	90-95	
8101106-7	1993	Furthermore, the p65 antisense oligomer effectively abolished an upregulation of CD11b that was produced by formyl-met-leu-phe and TPA.	N-Formylmethionine Leucyl-Phenylalanine	108-126	integrin subunit alpha M	Homo sapiens	81-86	
8100744-3	1993	Levels of labelled CD11b and CD18 increased after activation with the chemotactic peptide formyl-methionyl-leucyl phenylalanine (fMLP) in a dose- and time-dependent manner, but CD11a did not, indicating that CD11a would not be a useful marker of neutrophil activation.	N-Formylmethionine Leucyl-Phenylalanine	90-127	integrin subunit alpha M	Homo sapiens	19-24	
8454955-6	1993	We found more pronounced mobilization of Mac-1 on neutrophils than eosinophils after exposure to N-formylmethionyl-leucyl-phenylalanine, lipopolysaccharides, and activated sera (C5a).	N-Formylmethionine Leucyl-Phenylalanine	97-135	integrin subunit alpha M	Homo sapiens	41-46	
1982728-5	1990	There was decreased expression of CD11b/CD18 in pseudo-Pelger granulocytes with respect to controls (P less than 0.001) after stimulation with formyl-met-leu-phe (FMLP).	N-Formylmethionine Leucyl-Phenylalanine	143-161	integrin subunit alpha M	Homo sapiens	34-39	
2903896-6	1988	N-formyl-methionyl-leucyl-phenylalanine (fMLP) stimulation (10(-8) M, 15 min, 37 degrees C) significantly diminished Mac-1 in pre-gamma (-18% of total, P less than 0.05) but not beta fractions (+6% of total).	N-Formylmethionine Leucyl-Phenylalanine	41-45	integrin subunit alpha M	Homo sapiens	117-122